The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …

Global threat of carbapenem-resistant gram-negative bacteria

SS Jean, D Harnod, PR Hsueh - Frontiers in cellular and infection …, 2022 - frontiersin.org
Infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-
negative bacteria (GNB), including carbapenem-resistant (CR) Enterobacterales (CRE; …

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind …

RG Wunderink, Y Matsunaga, M Ariyasu… - The Lancet Infectious …, 2021 - thelancet.com
Background Nosocomial pneumonia due to multidrug-resistant Gram-negative pathogens
poses an increasing challenge. We compared the efficacy and safety of cefiderocol versus …

Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics

SJ Wood, TM Kuzel, SH Shafikhani - Cells, 2023 - mdpi.com
Pseudomonas aeruginosa is an important Gram-negative opportunistic pathogen which
causes many severe acute and chronic infections with high morbidity, and mortality rates as …

[HTML][HTML] How to manage Pseudomonas aeruginosa infections

M Bassetti, A Vena, A Croxatto, E Righi, B Guery - Drugs in context, 2018 - ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired
infections, especially in critically ill and immunocompromised patients. The major problem …

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the …

A Torres, MS Niederman, J Chastre… - European …, 2017 - Eur Respiratory Soc
The most recent European guidelines and task force reports on hospital-acquired
pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 …

Estimating the burden of antimicrobial resistance: a systematic literature review

NR Naylor, R Atun, N Zhu, K Kulasabanathan… - … Resistance & Infection …, 2018 - Springer
Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed
to establish the magnitude of this global threat in terms of both health and cost, and to …

Update of the treatment of nosocomial pneumonia in the ICU

R Zaragoza, P Vidal-Cortés, G Aguilar, M Borges… - Critical Care, 2020 - Springer
In accordance with the recommendations of, amongst others, the Surviving Sepsis
Campaign and the recently published European treatment guidelines for hospital-acquired …

Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis

M Serra-Burriel, M Keys, C Campillo-Artero, A Agodi… - PloS one, 2020 - journals.plos.org
Background Infections with multidrug resistant (MDR) bacteria in hospital settings have
substantial implications in terms of clinical and economic outcomes. However, due to clinical …

Management of pneumonia in critically ill patients

C Cillóniz, A Torres, MS Niederman - bmj, 2021 - bmj.com
Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …